Helius Medical Technologies Company
%20.jpg)
Helius had its beginnings in a lab at the University of Wisconsin-Madison. Now, we’re a publicly traded company on the Canadian Securities Exchange in Toronto, partnering with top organizations to pioneer unique, noninvasive platform technologies that support neurological wellness.
Total Funding:
$23.6M
Headquarters:
Newtown, Pennsylvania, United States
Funding Status:
IPO
Employee Number:
11-50
Last Funding Type:
Post-IPO Equity
Technology:
P4 Medicine
Investor Type:
For Profit
Investors Number:
1
Founded Date:
2014-01-01
Industry:
Biotechnology, Health Care, Health Diagnostics